Industry experts say a November 11, 2023, update to the Costa Rican biotechnology regulatory framework facilitates utilization of innovative biotechnologies and reduce barriers to common applications of modern biotechnology. FAS/San José expects a genome-edited banana variety resistant to yield-reducing fungal diseases sigatoka and fusarium wilt could be the first genome-edited product commercialized in Costa Rica later in 2024.
Mis- and disinformation are distorting science and public policy. Subscribe to our Daily and Weekly Digests for incisive coverage of ‘disruptive’ innovations in AI, agricultural biotechnology, food, chemicals, nuclear energy, vaccines, and other disruptive innovations.
Costa Rica was the world’s 5th largest exporter of bananas in 2023, shipping more than $430 million to the United States… Under the new regulation, Costa Rica would treat a range of products created with innovative biotechnologies as equivalent to conventional products.
[Editor’s note: Read the full report here]
